Cataract Clinical Trial
Official title:
Intraocular Lens Power Calculation Using Pre- and Intra-operative
Recently a prototype of a combination of an anterior segment OCT (VISANTE; Carl Zeiss
Meditec AG) and an operating microscope (OPMI 200; Carl Zeiss Meditec AG) was introduced
that allows measurements of the crystalline lens as well as the lens capsule itself after
removing the crystalline lens of cataract patients intra-operatively. This device uses OCT
technology to create high resolution B-scans (=images) of the anterior segment of the eye.
The OCT was shown to be highly reproducible for ACD measurements pre-operatively 12 and
small changes of the IOL/crystalline lens can be detected 13.
In a previous study (EK-10-125-0710) that was recently published in the journal
"Investigative Ophthalmology & Visual Science" it was shown that intra-operative
measurements of the anterior lens capsule improve the refractive outcome theoretically.14
However, in this previous study conventional eye models were used for IOL power calculation
and only the intra-operative measurement replaced pre-operative ACD measurements.
Aim of this study is to observe, whether the postoperative refractive outcome could be
improved theoretically by using both pre- and intra-operative measurements for retrospective
IOL power calculation with new eye models.
Since the introduction of optical biometry 1 (IOLMaster, Carl Zeiss Meditec AG, Jena,
Germany), as a reliable non-contact measurement of the axial eye length the influence of the
error of axial length measurement on the refractive error decreased from over 50% (when
measured with applanation ultrasound) to 36%. The mean error of corneal power measurement is
approximately 22% 2. These results show that the estimation of the post-operative
intra-ocular lens (IOL) position and therefore the estimated anterior chamber depth (ACD) is
nowadays the main source of error (35% 3 to 42% 2) in IOL power calculation and therefore
for the refractive outcome of the patients after cataract surgery. Early IOL power
calculation formulae, such as the Binkhorst I formula 4, used a fixed ACD value to predict
the position of the IOL, but the refractive results were not appropriate, because the
post-operative position of the IOL varied significantly between patients. Later observations
showed a correlation between the axial eye length and the post-operative ACD (longer=more
myopic eyes showed a larger ACD post-operatively). 5 These correlations were taken into
account in later developed formulas (such as the Binkhorst II formula). Olsen et al. 6
measured the post-operative ACD and substituted the predicted post-operative ACD with the
true, post-operative ACD in each case. The result after correcting the IOL position was a
highly accurate IOL power calculation, where no fudge factors were needed. Nowadays the
pre-operatively measured ACD is taken into account for several IOL power calculation
formulas, such as the Haigis formula, the Holladay II formula and the Olsen formula.
However, this new generation of formulas use the pre-operative ACD, without considering the
thickness of the crystalline lens. The ACD is measured as the distance between the anterior
surface of the cornea (anatomically correct would be the posterior surface of the cornea,
but in an optical context, as in IOL power calculations, the anterior surface is used) and
the anterior surface of the crystalline lens 2. Therefore the thickness of the crystalline
lens has a significant impact on the predicted post-operative position of the IOL. This
parameter was first taken into account by Olsen 7 and later modified by Norrby 8, 9. It
should be mentioned that IOL power calculations developed from theoretical calculations
based on Gaussian optics 10 to regression formulas, such as the SRK formula 11 that uses
retrospective data of a large number of patients. All these findings suggest that proper
measurements not only of the dimensions of the crystalline lens but also of the lens capsule
after removing the crystalline lens are necessary to improve IOL power calculation.
Recently a prototype of a combination of an anterior segment OCT (VISANTE; Carl Zeiss
Meditec AG) and an operating microscope (OPMI 200; Carl Zeiss Meditec AG) was introduced
that allows measurements of the crystalline lens as well as the lens capsule itself after
removing the crystalline lens of cataract patients intra-operatively. This device uses OCT
technology to create high resolution B-scans (=images) of the anterior segment of the eye.
The OCT was shown to be highly reproducible for ACD measurements pre-operatively 12 and
small changes of the IOL/crystalline lens can be detected 13.
In a previous study (EK-10-125-0710) that was recently published in the journal
"Investigative Ophthalmology & Visual Science" it was shown that intra-operative
measurements of the anterior lens capsule improve the refractive outcome theoretically.14
However, in this previous study conventional eye models were used for IOL power calculation
and only the intra-operative measurement replaced pre-operative ACD measurements.
Aim of this study is to observe, whether the postoperative refractive outcome could be
improved theoretically by using both pre- and intra-operative measurements for retrospective
IOL power calculation with new eye models.
;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
| Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
| Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
| Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
| Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
| Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
| Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
| Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
| Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
| Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
| Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
| Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
| Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
| Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
| Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
| Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
| Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
| Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
| Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
| Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |